<?xml version='1.0' encoding='utf-8'?>
<document id="23719968"><sentence text="Interaction of thiopental with esomeprazole in critically ill patients."><entity charOffset="31-43" id="DDI-PubMed.23719968.s1.e0" text="esomeprazole" /></sentence><sentence text="Thiopental is a thiobarbiturate given in the case of brain injuries to reduce intracranial pressure and to manage cerebral ischemia"><entity charOffset="16-31" id="DDI-PubMed.23719968.s2.e0" text="thiobarbiturate" /></sentence><sentence text=" A pharmacokinetic model has been described previously in critically ill patients with a different therapeutic strategy" /><sentence text=" New treatment options prompted us to investigate if drug-drug interactions occur" /><sentence text=" A new model is proposed describing the influence of concomitant administration of esomeprazole on the distribution of thiopental"><entity charOffset="83-95" id="DDI-PubMed.23719968.s5.e0" text="esomeprazole" /><entity charOffset="119-129" id="DDI-PubMed.23719968.s5.e1" text="thiopental" /><pair ddi="false" e1="DDI-PubMed.23719968.s5.e0" e2="DDI-PubMed.23719968.s5.e0" /><pair ddi="false" e1="DDI-PubMed.23719968.s5.e0" e2="DDI-PubMed.23719968.s5.e1" /></sentence><sentence text="" /><sentence text="The study population comprised 52 critically ill patients (body weight 47" /><sentence text="1-114 kg) aged 18-78 years who had been admitted into the critical care unit for treatment of intracranial hypertension" /><sentence text=" A total mean dose of 282" /><sentence text="8 ± 172" /><sentence text="7 mg/kg was given in 96 ± 72 h" /><sentence text=" Pharmacokinetic analysis was performed by using a nonlinear mixed-effect population model" /><sentence text="" /><sentence text="A one-compartment open model with first-order elimination identified two covariates, namely, body weight on clearance and volume of distribution, and the administration of esomeprazole on volume of distribution"><entity charOffset="172-184" id="DDI-PubMed.23719968.s14.e0" text="esomeprazole" /></sentence><sentence text=" The mean values (% relative standard error) for total clearance (CL) and for central volume of distribution (Vd) in patients with and without concomitant esomeprazole were 5"><entity charOffset="155-167" id="DDI-PubMed.23719968.s15.e0" text="esomeprazole" /></sentence><sentence text="3 L/h (9" /><sentence text="2 %) and 256" /><sentence text="1 (6" /><sentence text="4 %) and 153" /><sentence text="2 l (19" /><sentence text="2 %), respectively" /><sentence text="" /><sentence text="Based on these results, we conclude that concomitant administration of esomeprazole increases the volume of distribution and the half-live of thiopental"><entity charOffset="71-83" id="DDI-PubMed.23719968.s23.e0" text="esomeprazole" /><entity charOffset="142-152" id="DDI-PubMed.23719968.s23.e1" text="thiopental" /><pair ddi="false" e1="DDI-PubMed.23719968.s23.e0" e2="DDI-PubMed.23719968.s23.e0" /><pair ddi="false" e1="DDI-PubMed.23719968.s23.e0" e2="DDI-PubMed.23719968.s23.e1" /></sentence><sentence text=" This drug-drug interaction should be considered when a target concentration has to be reached" /><sentence text="" /></document>